Clinical trial on effects of homeopathic medicine made from cadamba on COVID-19

INTERVENTION: Intervention1: cadamba drug therapy: 1st 3 days 6 doses in every 2 hours QID 3 days then TDS for weeks potency 200 CONDITION: Health Condition 1: B972‐ Coronavirus as the cause of diseases classified elsewhere PRIMARY OUTCOME: with refrance to time scale T1‐T4 ‐‐ ; from 5‐7 weeks we expect complete recovery of patient who presented with initial symptoms. ; 1 patient should be asymptomatic with gental recovery (with serologically negative blood test) within 7‐14 days after administration of 1st dose of medicine. ; 2 asymptomatic patient (serologically positive) will remain asymptomatic and should be serologically negative after 7‐14 days of treatment.Timepoint: with refrance to time scale T1‐T4 ‐‐ ; from 5‐8 weeks we expect complete recovery of patient who presented with initial symptoms. SECONDARY OUTCOME: with refrance to time scale T1‐T5 ; if patient have late symptoms with initial pathological changes in vital organs we expect recovery by day 14 ; 1 we can conclude after the study is complete. ; Timepoint: (T1 to T5) ; T1‐ presentation before medicine intake. ; T2‐ observation for 1‐3 days after drug intake. ; T3‐ 3 to 7days gradual disappearance of initial symptoms. ; T4‐ after 7 days recovery expected. ; T5‐ If associated with other secondary complaints expected recovery is by 7‐14 days. INCLUSION CRITERIA: 1 COVID affected individual (serologically positive) symptomatic, mild hospitalized 2 asymptomatic (serologically positive)